CT Gel — Competitive Intelligence Brief

CT Gel (CT Gel) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical antimicrobial agent. Area: Dermatology.

phase 3 Topical antimicrobial agent Dermatology Small molecule

Target snapshot

CT Gel (CT Gel) — Stiefel, a GSK Company. CT Gel is a topical antimicrobial gel formulation designed to reduce bacterial colonization and biofilm formation on skin surfaces.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
CT Gel TARGET	CT Gel	Stiefel, a GSK Company	phase 3	Topical antimicrobial agent
Manuka honey	Manuka honey	University of Zagreb	marketed	Natural product / Topical antimicrobial agent
Silver sulfadiazine ointment	Silver sulfadiazine ointment	SCARM Institute, Tabriz, Iran	marketed	Topical antimicrobial agent	Bacterial cell wall and DNA; dihydropteroate synthase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical antimicrobial agent class)

1. SCARM Institute, Tabriz, Iran · 1 drug in this class
2. Stiefel, a GSK Company · 1 drug in this class